Literature DB >> 12719324

Long-term, low-intensity warfarin after idiopathic venous thromboembolism.

Daniel G Hackam1.   

Abstract

Entities:  

Year:  2003        PMID： 12719324      PMCID： PMC153690     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

Review 1.  Antithrombotic therapy for venous thromboembolic disease.

Authors:  T M Hyers; G Agnelli; R D Hull; T A Morris; M Samama; V Tapson; J G Weg
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.

Authors:  M M Bern; J J Lokich; S R Wallach; A Bothe; P N Benotti; C F Arkin; F A Greco; M Huberman; C Moore
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

Review 3.  How we diagnose and treat deep vein thrombosis.

Authors:  Jack Hirsh; Agnes Y Y Lee
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

4.  Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

Authors:  M Levine; J Hirsh; M Gent; A Arnold; D Warr; A Falanga; M Samosh; V Bramwell; K I Pritchard; D Stewart
Journal:  Lancet       Date:  1994-04-09       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.